Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 18 | 2024 | 1731 | 3.990 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 16 | 2024 | 1102 | 1.620 |
Why?
|
| Headache | 9 | 2024 | 1261 | 1.520 |
Why?
|
| Facial Pain | 2 | 2018 | 118 | 1.050 |
Why?
|
| Sleep | 18 | 2024 | 4823 | 1.040 |
Why?
|
| Headache Disorders | 2 | 2018 | 152 | 1.000 |
Why?
|
| Sleep Stages | 7 | 2016 | 705 | 0.980 |
Why?
|
| Peripheral Nervous System | 2 | 2020 | 151 | 0.770 |
Why?
|
| Sleep Apnea Syndromes | 13 | 2004 | 983 | 0.760 |
Why?
|
| Migraine without Aura | 2 | 2018 | 81 | 0.720 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.700 |
Why?
|
| Sleep Deprivation | 5 | 2016 | 849 | 0.640 |
Why?
|
| Pituitary-Adrenal System | 6 | 2014 | 552 | 0.630 |
Why?
|
| Hypothalamo-Hypophyseal System | 6 | 2014 | 701 | 0.590 |
Why?
|
| Papilledema | 1 | 2018 | 130 | 0.530 |
Why?
|
| Pseudotumor Cerebri | 1 | 2018 | 107 | 0.530 |
Why?
|
| Migraine with Aura | 1 | 2018 | 204 | 0.520 |
Why?
|
| Headache Disorders, Secondary | 1 | 2016 | 34 | 0.500 |
Why?
|
| Puerperal Disorders | 1 | 2018 | 305 | 0.480 |
Why?
|
| Central Nervous System | 2 | 2019 | 1342 | 0.470 |
Why?
|
| Giant Cell Arteritis | 1 | 2018 | 301 | 0.440 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 1465 | 0.410 |
Why?
|
| Sleep, REM | 6 | 2001 | 593 | 0.400 |
Why?
|
| Circadian Rhythm | 9 | 2004 | 2599 | 0.390 |
Why?
|
| Neuralgia | 1 | 2018 | 620 | 0.390 |
Why?
|
| Arousal | 4 | 2004 | 1175 | 0.380 |
Why?
|
| Suicide | 1 | 2023 | 1606 | 0.380 |
Why?
|
| Patient Care Team | 1 | 2022 | 2517 | 0.370 |
Why?
|
| Prader-Willi Syndrome | 3 | 1996 | 80 | 0.370 |
Why?
|
| Depression | 3 | 2023 | 8237 | 0.370 |
Why?
|
| Interleukin-6 | 7 | 2004 | 3229 | 0.360 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2335 | 0.320 |
Why?
|
| Disorders of Excessive Somnolence | 5 | 2000 | 279 | 0.310 |
Why?
|
| Polysomnography | 10 | 2016 | 1868 | 0.300 |
Why?
|
| Stress, Psychological | 2 | 2021 | 4528 | 0.300 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2016 | 1899 | 0.300 |
Why?
|
| Narcolepsy | 5 | 1999 | 200 | 0.300 |
Why?
|
| Obesity | 7 | 2016 | 13078 | 0.290 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1659 | 0.290 |
Why?
|
| Hydrocortisone | 9 | 2014 | 1832 | 0.290 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 1062 | 0.280 |
Why?
|
| Internet | 1 | 2019 | 3105 | 0.280 |
Why?
|
| Substance-Related Disorders | 1 | 2024 | 4416 | 0.280 |
Why?
|
| Adult | 45 | 2024 | 223109 | 0.270 |
Why?
|
| Humans | 67 | 2024 | 766011 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2004 | 4352 | 0.250 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 5508 | 0.240 |
Why?
|
| Genomics | 1 | 2020 | 5926 | 0.230 |
Why?
|
| Cytokines | 5 | 2004 | 7425 | 0.220 |
Why?
|
| Insulin Resistance | 3 | 2003 | 3989 | 0.210 |
Why?
|
| Genetic Variation | 1 | 2018 | 6607 | 0.210 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2001 | 618 | 0.200 |
Why?
|
| Greece | 1 | 2023 | 341 | 0.200 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 591 | 0.190 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2001 | 197 | 0.190 |
Why?
|
| Prospective Studies | 8 | 2024 | 54818 | 0.170 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2003 | 391 | 0.170 |
Why?
|
| Female | 38 | 2023 | 396159 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 3836 | 0.160 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2001 | 362 | 0.160 |
Why?
|
| Caffeine | 1 | 2024 | 702 | 0.160 |
Why?
|
| Community Health Centers | 1 | 2022 | 469 | 0.160 |
Why?
|
| Alcoholic Beverages | 1 | 2020 | 265 | 0.150 |
Why?
|
| MMPI | 2 | 1995 | 80 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 1997 | 6015 | 0.150 |
Why?
|
| Diagnosis, Differential | 6 | 2018 | 12969 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1657 | 0.140 |
Why?
|
| Growth Hormone | 1 | 1999 | 567 | 0.140 |
Why?
|
| Middle Aged | 29 | 2023 | 223058 | 0.140 |
Why?
|
| Anxiety Disorders | 1 | 2008 | 2740 | 0.140 |
Why?
|
| Depressive Disorder | 2 | 2008 | 3713 | 0.140 |
Why?
|
| Temporal Arteries | 1 | 2018 | 154 | 0.140 |
Why?
|
| Male | 38 | 2023 | 363808 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 18065 | 0.130 |
Why?
|
| Young Adult | 7 | 2023 | 59870 | 0.130 |
Why?
|
| Cataplexy | 1 | 1996 | 62 | 0.130 |
Why?
|
| Placebos | 1 | 2020 | 1659 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 1883 | 0.130 |
Why?
|
| Constipation | 1 | 2020 | 568 | 0.120 |
Why?
|
| Delta Sleep-Inducing Peptide | 1 | 1995 | 1 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1885 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1996 | 361 | 0.120 |
Why?
|
| Prevalence | 7 | 2016 | 15833 | 0.120 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 1039 | 0.120 |
Why?
|
| Sympathetic Nervous System | 1 | 1997 | 521 | 0.120 |
Why?
|
| Temazepam | 1 | 1994 | 6 | 0.110 |
Why?
|
| Triazolam | 1 | 1993 | 16 | 0.110 |
Why?
|
| Comorbidity | 5 | 2021 | 10572 | 0.110 |
Why?
|
| Porphyrias | 1 | 1993 | 56 | 0.110 |
Why?
|
| Fecal Incontinence | 1 | 1996 | 246 | 0.110 |
Why?
|
| Agoraphobia | 1 | 1993 | 176 | 0.110 |
Why?
|
| Dreams | 2 | 2008 | 145 | 0.100 |
Why?
|
| Fatigue | 1 | 2000 | 1551 | 0.100 |
Why?
|
| Face | 1 | 2018 | 1028 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4526 | 0.100 |
Why?
|
| Adolescent | 13 | 2023 | 88804 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2036 | 0.090 |
Why?
|
| Risk Factors | 6 | 2023 | 74870 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2018 | 1200 | 0.090 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 12800 | 0.090 |
Why?
|
| Incidence | 2 | 2021 | 21507 | 0.090 |
Why?
|
| Panic Disorder | 1 | 1993 | 611 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2021 | 24299 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 1995 | 1135 | 0.080 |
Why?
|
| Hunger | 1 | 2010 | 207 | 0.080 |
Why?
|
| Reference Values | 3 | 2001 | 4910 | 0.080 |
Why?
|
| Communication | 1 | 2022 | 3913 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2000 | 3849 | 0.070 |
Why?
|
| Leptin | 2 | 2010 | 1597 | 0.070 |
Why?
|
| Boston | 1 | 2021 | 9341 | 0.070 |
Why?
|
| Connecticut | 1 | 2008 | 365 | 0.070 |
Why?
|
| Exercise | 2 | 2023 | 5937 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3616 | 0.070 |
Why?
|
| Logistic Models | 1 | 2022 | 13271 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 4041 | 0.070 |
Why?
|
| Catecholamines | 2 | 1998 | 385 | 0.070 |
Why?
|
| Air Pollution | 1 | 2020 | 2380 | 0.070 |
Why?
|
| Respiratory Mechanics | 2 | 2001 | 719 | 0.070 |
Why?
|
| Body Mass Index | 6 | 2003 | 13044 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2020 | 41652 | 0.060 |
Why?
|
| Mental Disorders | 3 | 2000 | 6873 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8040 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2004 | 6425 | 0.060 |
Why?
|
| Weight Loss | 1 | 1995 | 2710 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 1994 | 1293 | 0.050 |
Why?
|
| United States | 3 | 2022 | 72914 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 10605 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 14751 | 0.050 |
Why?
|
| Adiponectin | 2 | 2010 | 1120 | 0.050 |
Why?
|
| Viscera | 1 | 2003 | 138 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2000 | 6209 | 0.050 |
Why?
|
| Child | 5 | 2023 | 80510 | 0.050 |
Why?
|
| Aging | 1 | 2001 | 8731 | 0.050 |
Why?
|
| Animals | 3 | 2024 | 168721 | 0.050 |
Why?
|
| Periodicity | 1 | 2002 | 347 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2020 | 22230 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 2 | 2003 | 752 | 0.040 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2020 | 27 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 10807 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 1995 | 626 | 0.040 |
Why?
|
| Chronic Disease | 3 | 2002 | 9355 | 0.040 |
Why?
|
| Somnambulism | 1 | 1999 | 13 | 0.040 |
Why?
|
| Weather | 1 | 2020 | 234 | 0.040 |
Why?
|
| Actigraphy | 1 | 2023 | 531 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7426 | 0.040 |
Why?
|
| Beverages | 1 | 2024 | 819 | 0.040 |
Why?
|
| Aged | 11 | 2016 | 171233 | 0.040 |
Why?
|
| Sheep | 1 | 2001 | 1440 | 0.040 |
Why?
|
| Insulin | 2 | 2004 | 6598 | 0.040 |
Why?
|
| Menopause | 2 | 2003 | 1661 | 0.040 |
Why?
|
| Electroencephalography | 3 | 2001 | 6274 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2001 | 1639 | 0.030 |
Why?
|
| Premenopause | 1 | 2001 | 1038 | 0.030 |
Why?
|
| Imipramine | 1 | 1996 | 96 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15887 | 0.030 |
Why?
|
| Hypoventilation | 1 | 1995 | 44 | 0.030 |
Why?
|
| Myoclonus | 1 | 1995 | 107 | 0.030 |
Why?
|
| Half-Life | 1 | 1995 | 644 | 0.030 |
Why?
|
| Time Factors | 3 | 2020 | 40117 | 0.030 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1996 | 427 | 0.030 |
Why?
|
| Causality | 1 | 2020 | 1247 | 0.030 |
Why?
|
| Quality of Life | 1 | 2016 | 13470 | 0.030 |
Why?
|
| Electrooculography | 1 | 1994 | 112 | 0.030 |
Why?
|
| Porphobilinogen | 1 | 1993 | 10 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 1995 | 365 | 0.030 |
Why?
|
| Nortriptyline | 1 | 1993 | 79 | 0.030 |
Why?
|
| Amnesia | 1 | 1995 | 257 | 0.030 |
Why?
|
| Clonazepam | 1 | 1993 | 135 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1997 | 1242 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 1998 | 639 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 1995 | 239 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 81786 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 1999 | 885 | 0.030 |
Why?
|
| Consumer Product Safety | 1 | 1993 | 122 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1995 | 633 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 2687 | 0.020 |
Why?
|
| Methylphenidate | 1 | 1996 | 480 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 1605 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 1995 | 713 | 0.020 |
Why?
|
| Body Composition | 1 | 2000 | 2441 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2010 | 8537 | 0.020 |
Why?
|
| Observer Variation | 1 | 1996 | 2611 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1995 | 995 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12433 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1996 | 2601 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 3051 | 0.020 |
Why?
|
| Testosterone | 1 | 2001 | 2495 | 0.020 |
Why?
|
| Respiration | 1 | 1996 | 1653 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 5990 | 0.020 |
Why?
|
| Psychotherapy | 1 | 1999 | 1649 | 0.020 |
Why?
|
| Specialization | 1 | 1994 | 779 | 0.020 |
Why?
|
| Anxiety | 2 | 1995 | 4674 | 0.020 |
Why?
|
| Saliva | 1 | 2014 | 851 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81522 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1996 | 2667 | 0.020 |
Why?
|
| Pennsylvania | 2 | 2002 | 616 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1998 | 6321 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 1997 | 20125 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4618 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9654 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 1996 | 1167 | 0.020 |
Why?
|
| Sampling Studies | 2 | 2000 | 610 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1994 | 1536 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 4249 | 0.020 |
Why?
|
| Memory | 1 | 1995 | 2191 | 0.020 |
Why?
|
| Age Factors | 2 | 2001 | 18384 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 8062 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14645 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15403 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10731 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13402 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17595 | 0.010 |
Why?
|
| Genotype | 1 | 1996 | 13024 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 11036 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2002 | 59526 | 0.010 |
Why?
|
| Hypertension | 1 | 2000 | 8627 | 0.010 |
Why?
|
| Heart Rate | 1 | 2010 | 4203 | 0.010 |
Why?
|
| Snoring | 1 | 2000 | 212 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2010 | 3210 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1998 | 382 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 20676 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1997 | 999 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1998 | 2268 | 0.010 |
Why?
|
| Age Distribution | 1 | 1998 | 2865 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42481 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 12060 | 0.000 |
Why?
|
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_